<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="tbl1" position="float">
 <label>Table 1</label>
 <caption>
  <p>Patient characteristics (intention-to-treat population).</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th rowspan="2">Characteristic</th>
    <th>ICT/CCRT (n = 77)
     <hr/>
    </th>
    <th>CCRT (n = 74)
     <hr/>
    </th>
    <th rowspan="2">
     <italic>p</italic>-value
    </th>
   </tr>
   <tr>
    <th>n (%)</th>
    <th>n (%)</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td colspan="4">Sex</td>
   </tr>
   <tr>
    <td> Male</td>
    <td>70 (90.9)</td>
    <td>70 (94.6)</td>
    <td>0.39</td>
   </tr>
   <tr>
    <td> Female</td>
    <td>7 (9.1)</td>
    <td>4 (5.4)</td>
    <td/>
   </tr>
   <tr>
    <td colspan="4">Age</td>
   </tr>
   <tr>
    <td> Mean</td>
    <td>51.2 ± 8.4</td>
    <td>52.0 ± 8.3</td>
    <td>0.89</td>
   </tr>
   <tr>
    <td> Range</td>
    <td>34–70</td>
    <td>34–68</td>
    <td/>
   </tr>
   <tr>
    <td colspan="4">ECOG Performance status</td>
   </tr>
   <tr>
    <td> 0</td>
    <td>18 (23.4)</td>
    <td>14 (18.9)</td>
    <td>0.73</td>
   </tr>
   <tr>
    <td> 1</td>
    <td>55 (71.4)</td>
    <td>57 (77.0)</td>
    <td/>
   </tr>
   <tr>
    <td> 2</td>
    <td>4 (5.2)</td>
    <td>3 (4.1)</td>
    <td/>
   </tr>
   <tr>
    <td colspan="4">Cancer site</td>
   </tr>
   <tr>
    <td> Oropharynx</td>
    <td>28 (36.4)</td>
    <td>34 (45.9)</td>
    <td>0.09</td>
   </tr>
   <tr>
    <td> Hypopharynx</td>
    <td>44 (57.1)</td>
    <td>30 (40.5)</td>
    <td/>
   </tr>
   <tr>
    <td> Larynx</td>
    <td>5 (6.5)</td>
    <td>10 (13.5)</td>
    <td/>
   </tr>
   <tr>
    <td colspan="4">Cancer site</td>
   </tr>
   <tr>
    <td> Oropharynx</td>
    <td>28 (36.4)</td>
    <td>34 (45.9)</td>
    <td>0.250</td>
   </tr>
   <tr>
    <td> Non-oropharynx</td>
    <td>49 (63.6)</td>
    <td>40 (54.1)</td>
    <td/>
   </tr>
   <tr>
    <td colspan="4">Tumor status</td>
   </tr>
   <tr>
    <td> T1</td>
    <td>8 (10.4)</td>
    <td>4 (5.4)</td>
    <td>0.41</td>
   </tr>
   <tr>
    <td> T2</td>
    <td>16 (20.8)</td>
    <td>11 (14.9)</td>
    <td/>
   </tr>
   <tr>
    <td> T3</td>
    <td>16 (20.8)</td>
    <td>12 (16.2)</td>
    <td/>
   </tr>
   <tr>
    <td> T4A</td>
    <td>27 (35.1)</td>
    <td>34 (45.9)</td>
    <td/>
   </tr>
   <tr>
    <td> T4B</td>
    <td>10 (13.0)</td>
    <td>13 (17.6)</td>
    <td/>
   </tr>
   <tr>
    <td colspan="4">Node status</td>
   </tr>
   <tr>
    <td> N0</td>
    <td>8 (10.3)</td>
    <td>10 (13.5)</td>
    <td>0.02</td>
   </tr>
   <tr>
    <td> N1</td>
    <td>3 (3.9)</td>
    <td>9 (12.2)</td>
    <td/>
   </tr>
   <tr>
    <td> N2</td>
    <td>53 (68.8)</td>
    <td>52 (70.3)</td>
    <td/>
   </tr>
   <tr>
    <td> N3</td>
    <td>13 (16.9)</td>
    <td>3 (4.1)</td>
    <td/>
   </tr>
   <tr>
    <td colspan="4">Stage</td>
   </tr>
   <tr>
    <td> III</td>
    <td>4 (5.2)</td>
    <td>8 (10.8)</td>
    <td>0.37</td>
   </tr>
   <tr>
    <td> IVA</td>
    <td>52 (67.5)</td>
    <td>50 (67.6)</td>
    <td/>
   </tr>
   <tr>
    <td> IVB</td>
    <td>21 (27.3)</td>
    <td>16 (21.6)</td>
    <td/>
   </tr>
   <tr>
    <td colspan="4">Stage</td>
   </tr>
   <tr>
    <td> III</td>
    <td>4 (5.2)</td>
    <td>8 (10.8)</td>
    <td>0.24</td>
   </tr>
   <tr>
    <td> IV</td>
    <td>73 (94.8)</td>
    <td>66 (89.2)</td>
    <td/>
   </tr>
   <tr>
    <td colspan="4">Resectability</td>
   </tr>
   <tr>
    <td> Resectable</td>
    <td>59 (76.6)</td>
    <td>56 (75.7)</td>
    <td>0.83</td>
   </tr>
   <tr>
    <td> Unresectable</td>
    <td>18 (23.4)</td>
    <td>18 (24.3)</td>
    <td/>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>Abbreviations: CCRT: concurrent chemoradiotherapy; ICT/CCRT: induction chemotherapy followed by concurrent chemoradiotherapy; ECOG: Eastern Cooperative Oncology Group.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
